Our results provide an epitranscriptomic molecular axis as the post-transcriptional mechanism in arsenic-induced tumorigenesis, and thus may help the development of new mechanism-based prevention and therapy by targeting FTO and m6A RNA methylation to reduce the skin cancer burden in arsenic-exposed individuals worldwide. The gene discussed is FTO; the disease is skin cancer.